News Focus
News Focus
Followers 178
Posts 16448
Boards Moderated 1
Alias Born 01/26/2016

Re: jman4956 post# 715454

Saturday, 08/24/2024 12:07:03 PM

Saturday, August 24, 2024 12:07:03 PM

Post# of 828428
jman4956,

The next Direct trial should/will be stopped very early for efficacy and followed for long term benefit. The efficacy will be so obvious that the Germans would stop it before anyone else if the trial has patients from that country on SOC. That’s the only reason I would like to see at least some patients compared to SOC because then they could be crossed over to treatment and be given the same chance as anyone else for a cure as long as they did not have totally compromised immune systems by then. This means enrolling SOC patients with at least as much life expectancy or a little more than those later enrolled in the Direct Phase 1 trial after inclusion criteria was raised up a little. Once Direct proves itself, true valuation will have no problem being found by the general investment community nor will the greatly decreased value of many big pharma products be ignored. At that point or just before someone will begin to short big pharma and go long NWBO. Free money for those so inclined. Keeping NWBO independent and wholly owned by current longs until then is the key to maximizing returns for these same. This is why I expect to see some major fireworks in 2025-2026. By that time many big pharma oncology products will be toast and they know it now already. This is why they are cutting back in early project research. Anyone who sells NWBO out of need or desire to help others in some way from now until then is understandable. Anyone who sells for any other reason except perhaps traders on hoped for swings until that point will miss out big time for no good purpose in my opinion. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News